VistaGen Therapeutics
VTGN
VTGN
56 hedge funds and large institutions have $8.12M invested in VistaGen Therapeutics in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 55 → 56 (+1)
8% less capital invested
Capital invested by funds: $8.84M → $8.12M (-$712K)
Holders
56
Holding in Top 10
–
Calls
$321K
Puts
$25K
Top Buyers
| 1 | +$358K | |
| 2 | +$167K | |
| 3 | +$142K | |
| 4 |
VA
Verdad Advisers
Boston,
Massachusetts
|
+$112K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$92.9K |
Top Sellers
| 1 | -$155K | |
| 2 | -$117K | |
| 3 | -$101K | |
| 4 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$68.4K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$52.4K |
